We are live on ! Find out more
CFM

Capricorn Fund Managers Portfolio holdings

AUM $1.27B
1-Year Est. Return 70.17%
This Fund
S&P 500
This Quarter Est. Return
+29.44%
1 Year Est. Return
+70.17%
3 Year Est. Return
+169.21%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$415M
AUM Growth
+$117M
Cap. Flow
+$84.1M
Cap. Flow %
20.26%
Top 10 Hldgs %
35.96%
Holding
106
New
47
Increased
17
Reduced
15
Closed
24

Top Buys

Rank Stock Value
1
ZYME icon
Zymeworks
ZYME
+$22.3M
2
GPCR icon
Structure Therapeutics
GPCR
+$10.3M
3
BLFS icon
BioLife Solutions
BLFS
+$9.91M
4
NUVB icon
Nuvation Bio
NUVB
+$9.84M
5
ALAB icon
Astera Labs
ALAB
+$8.36M

Top Sells

Rank Stock Value
1
TARS icon
Tarsus Pharmaceuticals
TARS
+$16.3M
2
VERA icon
Vera Therapeutics
VERA
+$13.1M
3
PHR icon
Phreesia
PHR
+$11.4M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$10.7M
5
REAL icon
The RealReal
REAL
+$10.4M

Sector Composition

Rank Sector Weight
1 Healthcare 44.36%
2 Technology 15.14%
3 Industrials 8.91%
4 Communication Services 8.61%
5 Consumer Discretionary 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZYME icon
1
Zymeworks
ZYME
$1.68B
$26.9M 6.49%
+1,022,840
New +$22.3M
WAY
2
Waystar Holding Corp
WAY
$4.56B
$24.2M 5.83%
738,263
+233,141
+46% +$8.31M
GPCR icon
3
Structure Therapeutics
GPCR
$3.53B
$17.6M 4.23%
+252,600
New +$10.3M
NUVB icon
4
Nuvation Bio
NUVB
$2.24B
$14.2M 3.43%
+1,588,854
New +$9.84M
MSFT icon
5
Microsoft
MSFT
$3.66T
$13.9M 3.35%
28,733
+1,415
+5% +$709K
GH icon
6
Guardant Health
GH
$21.4B
$11M 2.65%
107,787
+71,587
+198% +$6.4M
AMZN icon
7
Amazon
AMZN
$2.99T
$11M 2.65%
47,650
+3,231
+7% +$739K
KARO icon
8
Karooooo
KARO
$2B
$10.8M 2.61%
238,078
+67,322
+39% +$3.15M
EXAS
9
DELISTED
Exact Sciences
EXAS
$9.82M 2.37%
+96,685
New +$7.76M
GOOGL icon
10
Alphabet (Google) Class A
GOOGL
$4.62T
$9.72M 2.34%
31,066
-16,090
-34% -$4.6M
ROIV icon
11
Roivant Sciences
ROIV
$25B
$9.67M 2.33%
445,500
+247,000
+124% +$4.87M
BLFS icon
12
BioLife Solutions
BLFS
$1.59B
$9.15M 2.21%
+378,550
New +$9.91M
ALAB icon
13
Astera Labs
ALAB
$62B
$8.32M 2%
+50,000
New +$8.36M
V icon
14
Visa
V
$690B
$7.94M 1.91%
22,644
+2,495
+12% +$850K
SHC icon
15
Sotera Health
SHC
$5.16B
$7.94M 1.91%
+449,900
New +$7.44M
EA icon
16
Electronic Arts
EA
$52.9B
$7.88M 1.9%
+38,549
New +$7.78M
NSC icon
17
Norfolk Southern
NSC
$76.7B
$7.22M 1.74%
+25,000
New +$7.23M
OS
18
DELISTED
OneStream Inc
OS
$6.98M 1.68%
+380,000
New +$7.24M
TEX icon
19
Terex
TEX
$7.55B
$6.94M 1.67%
+130,000
New +$6.57M
HQY icon
20
HealthEquity
HQY
$8.78B
$6.93M 1.67%
+75,602
New +$7.24M
GTLS
21
DELISTED
Chart Industries
GTLS
$6.88M 1.66%
+33,383
New +$6.76M
PAHC icon
22
Phibro Animal Health
PAHC
$1.48B
$6.88M 1.66%
184,101
-68,827
-27% -$2.8M
GKOS icon
23
Glaukos
GKOS
$10.1B
$6.77M 1.63%
+60,000
New +$5.73M
CYBR
24
DELISTED
CyberArk
CYBR
$6.62M 1.6%
+14,841
New +$7.14M
LUXE
25
LuxExperience B.V.
LUXE
$1.16B
$6.3M 1.52%
754,909
+81,947
+12% +$731K
1
2 3 4 5

Similar funds

TC
Teilinger Capital Houston, Texas $1.27B AUM 5.87% 1-Year Est. Return
EIA
Edgemoor Investment Advisors Bethesda, Maryland $1.27B AUM 25.83% 1-Year Est. Return
CAM
Cozad Asset Management Champaign, Illinois $1.27B AUM 31.6% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
NCM
Novare Capital Management Charlotte, North Carolina $1.26B AUM 20.28% 1-Year Est. Return
TWP
Triad Wealth Partners Lawrence, Kansas $1.26B AUM 17.86% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return

Capricorn Fund Managers's Q4 2025 Portfolio in Review

As of Q4 2025, Capricorn Fund Managers held 106 positions worth $415M, up 39% from $298M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Capricorn Fund Managers deployed $84.1M of net new capital in Q4 2025, opening 47 new positions and adding to 17 existing holdings. Its largest new stake was Zymeworks: 1,022,840 shares worth $26.9M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 41% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Tarsus Pharmaceuticals, an estimated $16.3M trimmed.

  • Capricorn Fund Managers's largest Q4 2025 buy was Zymeworks: 1,022,840 shares worth $26.9M.
  • Capricorn Fund Managers added most to Waystar Holding Corp in Q4 2025, an estimated $8.31M increase.
  • Capricorn Fund Managers's biggest Q4 2025 reduction was Tarsus Pharmaceuticals, cutting an estimated $16.3M.
  • Capricorn Fund Managers fully exited Vera Therapeutics in Q4 2025, selling an estimated $13.1M.
  • Capricorn Fund Managers's ten largest holdings make up 36% of its $415M portfolio in Q4 2025.
  • Capricorn Fund Managers opened 47 new positions and closed 24 in Q4 2025.
  • Capricorn Fund Managers's portfolio value rose 39% quarter-over-quarter to $415M.

Based on Capricorn Fund Managers's 13F filing for Q4 2025, filed 21 Jan 2026.